| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCGA_PANCAN_2018 v0.0 | BRCA2 |
Lavinia Gordon gene: BRCA2 was added gene: BRCA2 was added to TCGA_PANCAN_2018. Sources: TCGA_PANCAN_2018 Mode of inheritance for gene: BRCA2 was set to Other Phenotypes for gene: BRCA2 were set to Fanconi anemia, complementation group D1; Hereditary breast and ovarian cancer syndrome |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||